Legal 'highs' available through the internet-implications and solutions?

QJM: An International Journal of Medicine

Volumn 103, Issue 7, 2010, Pages 535-536

  Jones, A L ^a  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; HERBACEOUS AGENT; ILLICIT DRUG; PHOSPHODIESTERASE INHIBITOR;

DRUG MARKETING; HUMAN; INTERNET; NOTE; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE;

EID: 77954292772     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq066     Document Type: Note

References (9)

1. Inciardi JA, Surratt HL, Cicero TJ, Rosenblum A, Ahwah C, Bailey JE, et al. Prescription drugs purchased through the internet: who are the end users? Ann Pharmacother 2005; 39:1634-9.
2. Jackson G, Arver S, Banks I, Stecher VJ. Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks. Int J Clin Pract 2010; 64:240-55.
3. Ghodse H. 'Uppers' keep going up. Br J Psychiatry 2007; 191:279-81.
4. Forman RF, Marlowe DB, McLellan AT. The Internet as a source of drugs of abuse. Curr Psychiatry Rep 2006; 8:377-82.
5. Schepis TS, Marlowe DB, Forman RF. The availability and portrayal of stimulants over the Internet. J Adolesc Health 2008; 42:458-65.
6. Dennehy CE, Tsourounis C, Miller AE. Evaluation of herbal dietary supplements marketed on the internet for recreational use. Ann Pharmacother 2005; 39:1634-9.
7. Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, et al. Purchasing 'legal highs' on the Internet-is there consistency in what you get? Q J Med 2010; 7:487-91.
8. Liang BA, Mackey T. Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales. American J Law Med 2009; 35:125-84.
9. Coleman JJ, Bensinger PB, Gold MS, Smith DE, Bianchi RP, DuPont RL. Can drug design inhibit abuse? J Psychoactive Drugs 2005; 37:343-62.